Analisis Keuangan Saham RNLX - Renalytix Plc - Depositary Receipt (Common Stock) (NasdaqCM) Stock

Gambaran Umum

Renalytix Plc is a prominent healthcare diagnostic company based in the United Kingdom. Specializing in artificial intelligence-enabled clinical diagnostics for kidney disease, the company plays a crucial role in transforming global kidney disease diagnosis and prognosis. One of its flagship solutions, KidneyIntelX, is a proprietary platform that uses a combination of biomarker data and sophisticated algorithms to assess the risk of progressive kidney disease in patients with type 2 diabetes and chronic kidney disease. This platform facilitates early detection, which is vital for timely intervention and management of the disease, addressing both a significant clinical need and reducing healthcare costs associated with advanced kidney care. Renalytix's efforts mark it as a leader in applying AI technology in nephrology, substantially contributing to more sustainable healthcare practices and outcomes.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai revenue untuk Renalytix Plc - Depositary Receipt (Common Stock) per 2024 Dec 31 adalah 2.89 MM.
Nilai operating income untuk Renalytix Plc - Depositary Receipt (Common Stock) per 2024 Dec 31 adalah -23.28 MM.
Nilai net income untuk Renalytix Plc - Depositary Receipt (Common Stock) per 2024 Dec 31 adalah -28.16 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2024-12-31	2.89	-23.28	-28.16
2024-09-30	2.35	-24.09	-28.03
2024-06-30	2.29	-28.89	-33.46
2024-03-31	2.22	-33.29	-37.49
2023-12-31	2.41	-38.08	-41.85
2023-09-30	2.89	-39.40	-43.81
2023-06-30	3.40	-42.24	-45.61
2023-03-31	3.72	-45.31	-39.66
2022-12-31	3.80	-48.96	-42.24
2022-09-30	3.46	-53.16	-47.12
2022-06-30	2.97	-53.30	-45.28
2022-03-31	2.61	-50.21	-49.94
2021-12-31	2.42	-43.84	-44.02
2021-09-30	1.97	-38.90	-37.61
2021-06-30	1.49	-32.89	-34.73
2021-03-31	1.02	-25.86	-27.88
2020-12-31	0.40	-20.09	-20.34
2020-09-30		-14.16	-15.59
2020-06-30

Laporan Laba Rugi: EPS

earnings per share basic untuk Renalytix Plc - Depositary Receipt (Common Stock) pada 2024 Dec 31 adalah -0.22.
laba per saham yang terdilusi untuk Renalytix Plc - Depositary Receipt (Common Stock) pada 2024 Dec 31 adalah -0.21.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2024-12-31	-0.22	-0.21
2024-09-30	-0.25	-0.25
2024-06-30	-0.31	-0.31
2024-03-31	-0.39	-0.38
2023-12-31	-0.45	-0.44
2023-09-30	-0.50	-0.50
2023-06-30	-0.55	-0.55
2023-03-31	-0.51	-0.56
2022-12-31	-0.57	-0.62
2022-09-30	-0.64	-0.69
2022-06-30	-0.62	-0.67
2022-03-31	-0.69	-0.70
2021-12-31	-0.61	-0.61
2021-09-30	-0.52	-0.53
2021-06-30	-0.49	-0.49
2021-03-31	-0.41	-0.41
2020-12-31	-0.31	-0.31
2020-09-30	-0.25	-0.25
2020-06-30	-0.17	-0.17

Arus Kas: Operasi, Investasi, Pendanaan

Nilai cash from operating activities untuk Renalytix Plc - Depositary Receipt (Common Stock) per 2024 Dec 31 adalah -26.86 MM.
Nilai cash from investing activities untuk Renalytix Plc - Depositary Receipt (Common Stock) per 2024 Dec 31 adalah 0.02 MM.
Nilai kas dari aktivitas pendanaan untuk Renalytix Plc - Depositary Receipt (Common Stock) per 2024 Dec 31 adalah 26.88 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2024-12-31	-26.86	0.02	26.88
2024-09-30	-24.44	-0.00	11.34
2024-06-30	-30.11	-0.00	10.25
2024-03-31	-30.92	0.06	2.36
2023-12-31	-36.16	0.06	16.35
2023-09-30	-36.47		16.27
2023-06-30	-34.09		16.39
2023-03-31	-39.62	0.00	41.80
2022-12-31	-36.84	-0.09	23.83
2022-09-30	-42.55	-0.41	24.48
2022-06-30	-45.92	-0.66	25.63
2022-03-31	-36.85	-0.94	0.57
2021-12-31	-37.57	-1.07	0.68
2021-09-30	-28.47	-1.45	0.57
2021-06-30	-28.40	-0.75	77.24
2021-03-31	-25.69	5.84	76.54
2020-12-31	-21.75	7.96	76.64
2020-09-30	-18.26	12.58	76.39
2020-06-30

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31	-5.07	10.95
2022-12-31		7.43	29.04
2022-09-30		3.31	3.31
2022-06-30	-3.64	6.19	3.31
2022-03-31
2021-12-31	-30.57	19.17	26.03
2021-09-30	-53.05	18.09	18.09
2021-06-30
2021-03-31	-14.36	4.90	6.33
2020-12-31	-19.85	3.62	4.35
2020-09-30	-25.13	4.50	5.60
2020-06-30	-34.94	8.99	17.15

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31	-0.19	-0.19
2022-12-31	-0.39	-0.28
2022-09-30	-0.77	-0.53
2022-06-30	-0.35	-0.23
2022-03-31	0.00	-0.00
2021-12-31	-0.03	-0.02
2021-09-30	-0.02	-0.01
2021-06-30
2021-03-31	-0.09	-0.00
2020-12-31	-0.07	-0.03
2020-09-30	-0.05	-0.02
2020-06-30	-0.03	-0.02

Efektivitas Manajemen

roa untuk Renalytix Plc - Depositary Receipt (Common Stock) pada 2024 Dec 31 adalah 0.00.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2024-12-31	0.00
2024-09-30	-1.92
2024-06-30	-0.94	-2.07
2024-03-31	-0.98	-2.01	-77.79	-33.82	-67.21
2023-12-31	-1.13	-2.32	-4.83	-1.89	-4.02
2023-09-30	-0.73	-1.07	-1.51	-0.54	-1.07
2023-06-30	-0.71	-1.04	-1.76	-0.64	-1.25
2023-03-31	-1.01	-1.53	-1.53	0.03	-1.53
2022-12-31	-0.70	-0.79	-1.57	-0.78	-1.42
2022-09-30	-0.74	-0.83	-2.47	-1.22	-2.23
2022-06-30	-0.50	-0.54	-1.30	-0.55	-1.05
2022-03-31	0.00	0.00	-1.70
2021-12-31	-0.33	-0.35	-0.61	-0.48	-0.47
2021-09-30	-0.41	-0.31	-0.62	-0.46	-0.33
2021-06-30	-0.75	-0.86	-0.33	0.55	-0.25
2021-03-31	-1.37	-1.47	-0.34	0.76	-0.33
2020-12-31	-0.46	-0.48	-0.18	0.58	-0.20
2020-09-30	-1.61	-0.55	-0.17	0.83	-0.21
2020-06-30	-0.95	-0.33	-0.25	0.16	-0.28

Gross Margins

marjin kotor untuk Renalytix Plc - Depositary Receipt (Common Stock) pada 2024 Dec 31 adalah 0.20.
marjin bersih untuk Renalytix Plc - Depositary Receipt (Common Stock) pada 2024 Dec 31 adalah -9.73.
marjin operasi untuk Renalytix Plc - Depositary Receipt (Common Stock) pada 2024 Dec 31 adalah -8.04.

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2024-12-31	0.20	-9.73	-8.04
2024-09-30	-0.02	-16.88	-14.99
2024-06-30	-0.02	-16.88	-14.99
2024-03-31	0.06	-17.36	-15.80
2023-12-31	0.14	-15.14	-13.62
2023-09-30	0.21	-13.58	-12.42
2023-06-30	0.29	-13.58	-12.42
2023-03-31	0.29	-10.67	-12.19
2022-12-31	0.26	-13.63	-15.38
2022-09-30	0.30	-13.63	-15.38
2022-06-30	0.30	-19.10	-19.22
2022-03-31		-19.13	-19.23
2021-12-31	0.45	-18.06	-19.02
2021-09-30	0.58	-19.06	-19.72
2021-06-30	0.46	-20.80	-21.87
2021-03-31	0.58	-26.78	-26.13
2020-12-31	0.36	-49.36	-52.14
2020-09-30	0.81	142.86	142.11
2020-06-30	0.81	88.10	105.50